DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Sweden
  • /
  • Household
Author Program NEWCreate Narrative
ESSITY B logo

Essity AB (publ) Stock Price

OM:ESSITY B Community·SEK 178.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 36 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ESSITY B Share Price Performance

SEK 262.70
8.90 (3.51%)
​
SEK 271.60
Fair Value
SEK 262.70
8.90 (3.51%)
3.3% undervalued intrinsic discount
SEK 271.60
Fair Value
Price SEK 262.70
AnalystConsensusTarget SEK 271.60
AnalystLowTarget SEK 215.00
AnalystHighTarget SEK 310.00
Wed, 29 Jul 26
Fair ValueSEK 271.60
Share Pricen/a

ESSITY B Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value SEK 271.6 3.3% undervalued intrinsic discount

Analysts Cite Trough Valuation and Limited Catalysts as Essity Price Targets Edge Lower

1users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value SEK 215 22.2% overvalued intrinsic discount

Regulatory Pressures And Cost Hikes Will Squeeze Hygiene Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value SEK 310 15.3% undervalued intrinsic discount

Aging Populations And Digitalization Will Expand Hygiene Demand Globally

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
ESSITY B logo
Essity
22.2% overvalued intrinsic discount

Regulatory Pressures And Cost Hikes Will Squeeze Hygiene Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 3 Sep
Read Narrative
ESSITY B logo
Essity
15.3% undervalued intrinsic discount

Aging Populations And Digitalization Will Expand Hygiene Demand Globally

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 12 Aug
Read Narrative
ESSITY B logo
Essity
3.3% undervalued intrinsic discount

Analysts Cite Trough Valuation and Limited Catalysts as Essity Price Targets Edge Lower

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 29 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
ESSITY B logo

ESSITY B: New Cost Inflation Cycle Will Continue To Pressure Margins

Fair Value: SEK 215 22.2% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
ESSITY B logo

ESSITY B: Business Review And Capital Returns Will Support Future Upside Potential

Fair Value: SEK 310 15.3% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
ESSITY B logo

ESSITY B: Cost Pressures And Tissue Review Will Shape Future Returns

Fair Value: SEK 271.6 3.3% undervalued intrinsic discount
19 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet and undervalued.

0 Risks
3 Rewards
View Full Analysis

Essity AB (publ) Key Details

SEK 137.6b

Revenue

SEK 91.8b

Cost of Revenue

SEK 45.8b

Gross Profit

SEK 33.7b

Other Expenses

SEK 12.1b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 22, 2026
17.88
33.29%
8.81%
45.7%
View Full Analysis

About ESSITY B

Founded
1849
Employees
36000
CEO
Ulrika Kolsrud
WebsiteView website
www.essity.com

Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family carers, professional caregivers, and patients and consumers through pharmacies, medical device stores, hospitals, distributors, care institutions, and e-commerce. The Consumer Goods segment provides pads, panty liners, tampons, diapers, wet wipes, shampoos, lotions, baby oil, skin creams, intimate soaps, intimate wipes, leakproof apparel, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins under the TENA, Knix, Modibodi, Libero, Lotus, Libresse, Bodyform, Nana, Saba, Nosotras, TOM Organic, Tempo, Zewa, Cushelle, Plenty, Regio, and Familia brands through retail trade and e-commerce. The Professional Hygiene segment offers toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products, as well as vision cleaning and data-driven cleaning solutions under the Tork brand to companies and office buildings, universities, healthcare facilities, airports, industries, restaurants, hotels, stadiums, and other public venues through direct to the end-customer, e-commerce, or distributors. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.

Recent ESSITY B News & Updates

User avatar
Narrative Update • Sep 03

ESSITY B: New Cost Inflation Cycle Will Continue To Pressure Margins

Essity's analyst price target has been reset lower from about SEK 219 to SEK 215, as analysts factor in fresh Sell ratings, lower SEK-based targets, concerns about a new cost inflation cycle, and potential downside risk to consensus estimates. Analyst Commentary Recent Street research on Essity shows a clear split in views, with some investors seeing long term upside potential and others focusing on emerging risks.
User avatar
Narrative Update • Aug 12

ESSITY B: Business Review And Capital Returns Will Support Future Upside Potential

Essity's updated analyst price target has shifted to SEK 310 from SEK 300 as analysts factor in a slightly higher discount rate, a different balance of revenue growth and profit margin expectations, and recent Street research highlighting potential downside risk to consensus estimates due to pricing lagging input cost inflation. What’s in the News for Essity Essity has opened a new recycled fiber facility in the UK that expands capacity and strengthens domestic fiber supply for hygiene paper products, supporting more circular production.

Recent updates

No updates

Essity AB (publ) Competitors

View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide